Legend Biotech (LEGN) Retained Earnings (2019 - 2026)
Legend Biotech's (LEGN) quarterly Retained Earnings came in at $967.6 million in Q1 2026, down 4.91% YoY from $1.0 billion in Q1 2025, and down 3.43% on a QoQ basis from $1.0 billion in Q4 2025.
Legend Biotech (LEGN) Retained Earnings (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Retained Earnings data on file, last reported at $967.6 million in Q1 2026.
- Quarterly Retained Earnings fell 4.91% year-over-year to $967.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $967.6 million (down 4.91% YoY) and the FY2025 annual result came in at $1.0 billion, down 3.7% from the prior year.
- Retained Earnings retreated to $967.6 million in Q1 2026, from $1.0 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.4 billion in Q2 2023 to a low of $562.6 million in Q2 2022.
- A 5-year average of $1.0 billion and a median of $1.0 billion in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 381546.94% — and 2024, when it dropped 17.63%.
- Tracing LEGN's Retained Earnings over 5 years: stood at $744.0 million in 2022, then jumped by 68.19% to $1.3 billion in 2023, then fell by 16.85% to $1.0 billion in 2024, then slipped by 3.7% to $1.0 billion in 2025, then decreased by 3.43% to $967.6 million in 2026.
- The last three Retained Earnings figures came in at $967.6 million (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 1.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 967.60 Mn |
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.34 Bn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 653.10 Mn |
| Dec 31, 2022 | 744.00 Mn |
| Sep 30, 2022 | 861.90 Mn |
| Jun 30, 2022 | 562.60 Mn |
| Mar 31, 2022 | 741.13 Mn |
| Dec 31, 2021 | 766.00 Mn |
| Sep 30, 2021 | 225,837.00 |